文献速递肿瘤 PET/CT

多参数功能成像评估卵巢癌腹膜肿瘤负荷的性能

Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该回顾性研究纳入84例FIGO IIIC–IV期卵巢癌患者,评估治疗前18F-FDG PET/CT定量腹膜代谢图谱与分期腹腔镜相比的临床效用。MTV是与腹膜癌指数评分相关性最好的代谢参数(Spearman ρ=0.380,P<0.001),在上腹部区域诊断腹膜受累的AUC为0.740–0.765,在小肠区域为0.591–0.681,在盆腔区域6降至0.487。18F-FDG PET/CT较单独CT使35例(41.6%)从IIIC期上调至IV期,并导致超过三分之一患者的治疗修改。

要点

  • MTV是与腹膜癌指数评分相关性最好的代谢参数(ρ=0.380,P<0.001)。
  • MTV诊断腹膜受累的AUC在上腹部为0.740–0.765,小肠区域为0.591–0.681,盆腔区域6为0.487。
  • 18F-FDG PET/CT较单独CT使35例(41.6%)从IIIC期上调至IV期。

核心结论

  • 18F-FDG PET/CT代谢参数能高度准确反映腹膜肿瘤负荷,诊断价值因解剖区域而异。
  • MTV是评估腹膜肿瘤扩展最具代表性的代谢参数。

研究设计与样本

  • 回顾性分析前瞻性收集的84例FIGO IIIC至IV期卵巢癌患者数据。
  • 所有患者均接受双盲18F-FDG PET/CT审阅。
  • 以受试者工作特征曲线下面积(AUC)评估代谢参数按腹膜癌指数在13个腹部区域识别腹膜癌的判别能力。

主要发现

  • MTV在预测腹膜扩展方面与腹膜癌指数评分的Spearman ρ为0.380(P<0.001)。
  • MTV诊断上腹部(区域1、2和3)腹膜受累的AUC为0.740至0.765。
  • MTV在小肠区域(9-12)的AUC较低,为0.591至0.681,在盆腔区域6降至0.487。
  • 18F-FDG PET/CT较单独CT使35例(41.6%)从IIIC期上调至IV期。
  • 18F-FDG PET/CT导致超过三分之一患者的治疗修改。

临床怎么用

  • 治疗前18F-FDG PET/CT定量MTV可用于评估卵巢癌腹膜肿瘤负荷,但需注意诊断价值因解剖区域而异。
  • 18F-FDG PET/CT有助于检测腹外病变并上调分期,可能影响治疗决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the study was to evaluate the clinical utility of pretreatment 18F-FDG PET/CT with quantitative evaluation of peritoneal metabolic cartography in relation to staging laparoscopy for ovarian carcinomatosis. PATIENTS AND METHODS: A retrospective review of prospectively collected data from 84 patients with FIGO (International Federation of Gynecology and Obstetrics) stage IIIC to IV ovarian cancer was carried out. All patients had a double-blinded 18F-FDG PET/CT review. Discriminant capacity of metabolic parameters to identify peritoneal carcinomatosis in the 13 abdominal regions according to the peritoneal cancer index was estimated with area under the receiver operating characteristic curve (AUC). RESULTS: The metabolic parameter showing the best trade-off between sensitivity and specificity to predict peritoneal extension compared with peritoneal cancer index score was the metabolic tumor volume (MTV), with a Spearman ρ equal to 0.380 (P < 0.001). The AUC of MTV to diagnose peritoneal involvement in the upper abdomen (regions 1, 2, and 3) ranged from 0.740 to 0.765. MTV AUC values were lower in the small bowel regions (9-12), ranging from 0.591 to 0.681, and decreased to 0.487 in the pelvic region 6. 18F-FDG PET/CT also improved the detection of extra-abdominal disease, upstaging 35 patients (41.6%) from stage IIIC to IV compared with CT alone and leading to treatment modification in more than one third of patients. CONCLUSIONS: 18F-FDG PET/CT metrics are highly accurate to reflect peritoneal tumor burden, with variable diagnostic value depending on the anatomic region. MTV is the most representative metabolic parameter to assess peritoneal tumor extension.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mallet E, Angeles MA, Cabarrou B, et al. Performance of Multiparametric Functional Imaging to Assess Peritoneal Tumor Burden in Ovarian Cancer. Clin Nucl Med. 2021. PMID: 34238796. doi:10.1097/RLU.0000000000003785

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。